Fig. 4From: Consistency of efficacy results across various clinical measures and statistical methods in the lecanemab phase 2 trial of early Alzheimer’s diseaseADAS-Cog14 results for dose regimens 10M and 10BW versus placebo across the statistical methods. A Primary. B DPM. C Natural cubic spline. D QMM. E Primary model + base visit. F Primary model + base * visit + TRT * Apoe4 + visit * Apoe4 + 3-way interaction terms. P values are two-sidedBack to article page